Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow-up.
M RomagnuoloL AngileriSimona TavecchioAngelo Valerio MarzanoS FerrucciPublished in: Clinical and experimental dermatology (2020)